It might not be as fancy, but this is how interested AZ is in kidney disease, and this is just one big pharma company...
Someone might want some propagermanium to get an edge...
- Forums
- ASX - By Stock
- DXB
- Ann: Dimerix Confirms Phase 3 FSGS Study Design With EMA
Ann: Dimerix Confirms Phase 3 FSGS Study Design With EMA, page-24
-
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DXB (ASX) to my watchlist
(20min delay)
|
|||||
Last
47.0¢ |
Change
-0.020(4.08%) |
Mkt cap ! $266.8M |
Open | High | Low | Value | Volume |
49.5¢ | 49.5¢ | 46.5¢ | $679.0K | 1.410M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 130349 | 46.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
47.0¢ | 5099 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 130349 | 0.465 |
10 | 255767 | 0.460 |
8 | 141497 | 0.455 |
7 | 97903 | 0.450 |
5 | 613752 | 0.445 |
Price($) | Vol. | No. |
---|---|---|
0.470 | 5099 | 3 |
0.475 | 18453 | 2 |
0.480 | 89300 | 6 |
0.485 | 115396 | 2 |
0.490 | 51122 | 4 |
Last trade - 12.26pm 15/07/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |